CLASS II ONGOING Device recall · Reported 4 Oct 2023 · FDA Enforcement Report

aView 2 A Monitor-The Ambu aView 2 Advance is intended recalled

Ambu is recalling aView 2 A Monitor-The Ambu aView 2 Advance is intended to display live imaging data from, distributed nationwide in the US. The recall was initiated on 21 Jul 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI: 5707480145089 Version no.: 054 thru 056; 058 thru 059 Product manufactured prior to Oct 29, 2020
Quantity recalled2689 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2628-2023
FDA event ID
92886
Recalling firm
Ambu, Columbia, MD
Classification
Class II
Status
Ongoing
Recall initiated
21 Jul 2023
FDA classified
22 Sep 2023
Reported
4 Oct 2023
Type
Voluntary: Firm initiated
Customers notified by
Visit
Reason category
Device Malfunction

Timeline

21 Jul 2023Recall initiated by company
22 Sep 2023Classified by FDA+63 days
4 Oct 2023Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Multiple impacts, for example from being dropped, can cause to the Ambu aView 2 Advance to short-circuit and under special circumstances make the lithium-ion battery in the device combust leading to smoke and flames

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Ambu aView 2 A Monitor-The Ambu aView 2 Advance is intended to display live imaging data from compatible Ambu visualization devices, portable endoscopy system. Catalog No: 405011000

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Multiple impacts, for example from being dropped, can cause to the Ambu aView 2 Advance to short-circuit and under special circumstances make the lithium-ion battery in the device combust leading to smoke and flames

Which lots are affected?

UDI: 5707480145089 Version no.: 054 thru 056; 058 thru 059 Product manufactured prior to Oct 29, 2020

Where was it sold?

Nationwide

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Ambu

All 7
ReportedClassRecallCompanyReasonWhere
DeviceCLASS ISpur II Labeled as the following recalled by AmbuAmbuOtherNationwide
DeviceCLASS IIaScope" 5 Broncho HD 5.6/2.8 Sampler Set recalled by AmbuAmbuLabeling ErrorsNationwide
DeviceCLASS IIAmbu¿ VivaSight 2 DLT Endobronchial tube recalledAmbuOtherNationwide
DeviceCLASS IIaView 2 A Monitor recalled by AmbuAmbuPackaging DefectsNationwide
DeviceCLASS IIVivaSight 2 DLT recalled by AmbuAmbuPackaging DefectsNationwide

Other Surgical Instruments recalls

All 3,891